Multi-factorial Etiology of Gallbladder Cancer: A USA Case-Control Population Study by Hamadeh, Grace et al.
Multi-factorial Etiology of Gallbladder Cancer: A USA Case-Control 
Population Study 
Grace Hamadeh1,2 , Aishwarya Lanka3, Akram Shalaby MB BCh.3, Rikita Hatia M.P.H 2, Ahmed Shalaby, MB BCh.3, 
Adam Khalifa 2, Donghui Li, Ph.D.3, Milind Javle, M.D. 3, Manal Hassan, MB BCh., M.P.H., Ph.D. 2
1. Department of Biomedical Sciences, Texas A&M University 
2. Department of Epidemiology, The University of Texas MD Anderson Cancer Center





Gallbladder Cancer (GBC) in USA
• Globally rare, asymptomatic, lethal cancer known for late diagnosis and 
poor prognosis1,2
• Between 2007-2011, 3,700 GBC cases and 2,000 deaths (1.13 cases and 
0.62 deaths per 100,000) 1
• 5-20% five-year survival rate and mean survival of 2-52 months 3
• Possible risk factors include: cholecystitis, gallstones, smoking, alcohol, 
female gender, race, and environmental toxins  3,4
Research Question
1. Is GBC incidence dependent on specific demographic 
characteristics?
2. What are the main environmental factors associated with GBC risk? 
3. Which female factors contribute to the risk of GBC?
4. What chronic conditions are associated with GBC?
5. Is there an association between GBC and steatosis after adjustment 
for potential cofounders?
• Hospital-based case - control study conducted at UT MD 
Anderson Cancer (2017-2021).
Inclusion Criteria 
• Cases: 79 patients with confirmed GBC diagnosis who reside in 
the US, without previous history of other cancers
• Controls: 660 healthy individuals without prior history of cancer, 
who are spouses of cancer patients (excluding GI or smoking-
related cancer) 
• No restrictions by age, gender, or race 
• All participants interviewed for prior history of GBC were 
reviewed for evidence of GBC and other GI Cancers 
(radiologically and clinically).
Statistical Analysis
• SPSS and STATA statistical softwares used to perform 
multivariable logistic regression to estimate odds ratios. 
• Assess the independent effect and significance (p < 0.05) of 
multiple risk factors including cigarette smoking, alcohol 
drinking, diabetes, thyroid diseases, obesity, hormones, and 
family history of cancer 
• Adjusted OR (AOR) and 95% Confidence Interval (95% CI) 
values calculated for each factor
• All AORs were adjusted for age, gender, race, educational level 
and marital status
• Analyses were performed in men and women separately and all 
populations.
• GBC was more common in females, non-white races, and non-married
individuals. The geographical variation observed was most likely due to the
referral pattern of patients.
• Gallbladder inflammation was related to 8 times higher risk for GBC.
• Alcohol users had approximately two-fold higher risk for GBC.
• Restricted analysis among 44 women cases and 257 women controls
yielded 94% reduction in GBC risk among estrogen users (the reduction
was associated with the duration of estrogen intake).
• Despite that 19% of the GBC patients had pathological evidence of
steatosis, obesity and diabetes was not significantly related to GBC risk.
• The most prevalent chronic medical conditions in patients with GBC were
high blood pressure, polyps, gallbladder stones, gallbladder inflammation,
and fatty liver. (Note: Prevalence of chronic medical conditions was not studied in
control group)
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• GBC is multi-factorial in origin
• Control of environmental exposures (alcohol use) may reduce GBC 
susceptibility and promote primary prevention
• Patients with high risk factors such as GBD and cholecystitis should 
be considered for early GBC prevention and screening programs 
• Mechanistic pathway for GBC with GBD and cholecystitis needs to 
be further explored 
• Limitation of this study was small sample size due to GBC rarity 
• Further validation of GBC risk factors is necessary as it will help 
confirm findings and develop diagnostic markers and early treatments 
of GBC. 
• Strategic planning of prevention and management of GBC should be 
further investigated and developed by healthcare providers.
Figure 2 Summary: 
• No significant variation between cases and controls in terms of duration of female 
factors such as the duration of progesterone, estrogen, birth control, menopause 
age, menstruation age, and hysterectomy age. 
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Figure 1 Summary:
• High prevalence of chronic medical conditions: gallbladder inflammation (51.9%), HBP
or high blood pressure (48.1%), gallbladder stones (44.3%), and polyps (30.4%).
• Medium prevalence of chronic medical conditions: fatty liver (18.9%), diabetes history
(15.2%), angina or ischemic chest pain (10.1%), DVT or deep vein thrombosis (8.9%), and
hypothyroidism (8.9%)
• Low prevalence of chronic medical conditions: renal stones (6.3%), ovarian cysts (5.1%),
stroke (3.8%), atherosclerosis (3.8%), bronchial asthma (3.8%), anti-BC (3.8%), HBs
(2.5%), HCV (2.5%), varicose veins (2.5%), ulcerative colitis (2.5%), hyperthyroidism
(2.5%), renal impairment (1.3%), and duodenal ulcer (1.3%).
Table 1: Demographic Characteristics of the Study Populations [79 cases 
and 660 controls]
*Adjacent states include Louisiana, Arkansas, Oklahoma, and New Mexico
Prevalence of Various Chronic Medical Conditions in Patients with GBC 
Table 3: Estimated Odds Ratios (OR), 95% Confidence Interval (CI) 
of Female Factors: Multivariable Logistic Regression Analysis 
*ORs are adjusted for age, race, alcohol drinking, menopausal age, gallbladder stones or inflammation, and marital status 
Summary Statistics for Tables 1 & 2: 
• Table 1: Significance variation was observed in race, gender, marital status, and the
resident state of Texas and its adjacent states.
• Table 2: Increase of GBC risk was observed in the female-gender, non-white race,
non-married marital status, alcohol history, and gallstone history.
Table 2: Estimated Odds Ratios (OR), 95% Confidence Interval (CI) of 
different exposures: Multivariable Logistic Regression Analysis 
Results
Conclusions & Future Implications
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Results
Summary Statics for Table 3:
• 94% decrease in the risk of GBC among women who have had estrogen exposure
• Females who used estrogen for less than or equal to two years have an 85% decrease in
risk of GBC
• GBC protection increased when estrogen was used for 2+ years, decreasing risk by 96%
• Other female factors were not significantly associated with GBC such as birth control
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Male 35 (44.3) 403 (61.1)
Female 44 (55.7) 257 (38.9)
Race <0.001
White 56 (70.9) 596 (90.3)
African American 8 (10.1) 19 (2.9)
Hispanics 9 (11.4) 41 (6.2)
Asian/Pacific Islander 6 (7.6) 4 (0.6)
Age (Years) 0.849
<=40 3 (3.8) 25 (3.8)
41-50 13 (16.5) 101 (15.3)
51-60 20 (25.3) 209 (31.7)
61-70 30 (38) 224 (33.9)
>70 13 (16.5) 101 (15.3)
Education Level 0.150
<= High School 22 (27.8) 145 (22)
>High School 57 (72.2) 515 (78)
Marital Status <0.001
Single 17 (21.5) 44 (6.7)
Married 62 (78.5) 616 (93.3)
Resident State <0.001
Texas & Adjacent States 43 (54.4) 487 (73.8)





OR (95% CI) P value
Age 0.231
Above age of 50 63 (79.7) 534 (80.9) 1 (reference)
Below age of 50 16 (20.3) 126 (19.1) 1.02 (0.99-1.05)
Race <0.001
Non-white 23 (29.1) 596 (90.3) 1 (reference)
White 56 (70.9) 64 (9.7) 0.21 (0.11-0.42)
Gender 0.005
Male 35 (44.3) 403 (61.1) 1 (reference)
Female 44 (55.7) 257 (38.9) 1.97 (1.23-3.16)
Cigarette Smoking 0.151
Nonsmokers 49 (62) 353 (53.5) 1 (reference)
Smokers 30 (38) 307 (46.5) 0.70(0.44-1.14)
Marital Status 0.005
Not Married 17 (21.5) 44 (6.7) 1 (reference)
Married 62 (78.5) 616 (93.3) 0.26 (0.14- 0.48)
Alcohol History 0.027
Non-drinkers 34 (43) 295 (44.7) 1 (reference)
Drinkers 45 (57) 365 (55.3) 1.97 (1.08-3.58)
Education 0.997
>Highschool 57 (72.2) 515 (78) 1 (reference)
<=Highschool 22 (27.8) 145 (22) 1.00 (0.55-1.84)
Diabetes History 0.406
Non-diabetic 67 (84.8) 581 (88) 1 (reference)
Diabetic 12 (15.2) 079 (12) 0.70(0.30-1.62)
Adulthood history of Obesity 0.666
Non-obese 55 (69.6) 458 (69.4) 1 (reference)




No 38 (48.1) 585 (88.6) 1 (reference)
Yes 41 (51.9) 75 (11.4) 7.97(4.52-14.06)
Family History of Cancer 0.158
No 20 (25.3) 228 (34.5) 1 (reference)
Yes 59 (74.7) 432 (65.5) 1.53(0.85-2.77)
History of Hypothyroidism 0.533
No 72 (91.1) 600 (90.9) 1 (reference)





OR (95% CI)* P value
Birth Control History 0.084
No 9 (20.9) 63 (24.9) 1 (reference)
Yes 34 (79.1) 190 (75.1) 2.89(0.87-9.64)
Hysterectomy History 0.161
No 30 (68.2) 123 (48.6) 1 (reference)
Yes 14 (31.8) 130 (51.4) 0.45(0.15-1.37)
History of ever Estrogen use <0.001
No 37 (84.1) 96 (37.4) 1 (reference)
Yes 7 (15.9) 161 (62.6) 0.06(0.02-0.22)
=< 2 years of Estrogen use 3 (6.8) 29 (11.3) 0.15(0.04-0.66) .012
>2 years of Estrogen use 4 (9.1) 132 (51.4) 0.04(0.01-0.15) <0.001
History of ever Progesterone use
No 39 (88.6) 200 (77.8) 1 (reference)
Yes 5 (11.4) 57 (22.2) 1.09(0.27-4.48)
